标题
Towards Comprehension of the ABCB1/P-Glycoprotein Role in Chronic Myeloid Leukemia
作者
关键词
-
出版物
MOLECULES
Volume 23, Issue 1, Pages 119
出版商
MDPI AG
发表日期
2018-01-09
DOI
10.3390/molecules23010119
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- MicroRNAs that affect the Fanconi Anemia/BRCA pathway are downregulated in imatinib-resistant chronic myeloid leukemia patients without detectable BCR-ABL kinase domain mutations
- (2017) E Yap et al. LEUKEMIA RESEARCH
- Expression Profiling of Circulating Microvesicles Reveals Intercellular Transmission of Oncogenic Pathways
- (2017) Gloria Milani et al. MOLECULAR CANCER RESEARCH
- miR-9 regulates the multidrug resistance of chronic myelogenous leukemia by targeting ABCB1
- (2017) Yan Li et al. ONCOLOGY REPORTS
- Toward a Better Understanding of the Complexity of Cancer Drug Resistance
- (2016) Michael M. Gottesman et al. Annual Review of Pharmacology and Toxicology
- Multidrug resistant tumour cells shed more microvesicle-like EVs and less exosomes than their drug-sensitive counterpart cells
- (2016) Vanessa Lopes-Rodrigues et al. BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS
- Chemosensitizing effects of synthetic curcumin analogs on human multi-drug resistance leukemic cells
- (2016) Sariya Mapoung et al. CHEMICO-BIOLOGICAL INTERACTIONS
- Chronic myelogenous leukaemia exosomes modulate bone marrow microenvironment through activation of epidermal growth factor receptor
- (2016) Chiara Corrado et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Influence of CYP3A5*3 and ABCB1 C3435T on clinical outcomes and trough plasma concentrations of imatinib in Nigerians with chronic myeloid leukaemia
- (2016) B. A. Adeagbo et al. JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS
- The clinical significance of ABCB1 overexpression in predicting outcome of CML patients undergoing first-line imatinib treatment
- (2016) L N Eadie et al. LEUKEMIA
- Long-term benefits and risks of frontline nilotinib vs imatinib for chronic myeloid leukemia in chronic phase: 5-year update of the randomized ENESTnd trial
- (2016) A Hochhaus et al. LEUKEMIA
- Low ABCB1 and high OCT1 levels play a favorable role in the molecular response to imatinib in CML patients in the community clinical practice
- (2016) Flavia da Cunha Vasconcelos et al. LEUKEMIA RESEARCH
- Natural course and biology of CML
- (2015) Bradley Chereda et al. ANNALS OF HEMATOLOGY
- NFκB Pathway and microRNA-9 and -21 are Involved in Sensitivity to the Pterocarpanquinone LQB-118 in Different CML Cell Lines
- (2015) Fernanda de Faria et al. Anti-Cancer Agents in Medicinal Chemistry
- BCR-ABL Mutations in Chronic Myeloid Leukemia Treated With Tyrosine Kinase Inhibitors and Impact on Survival
- (2015) Katia Borgia Barbosa Pagnano et al. CANCER INVESTIGATION
- Chronic myeloid leukemia-derived exosomes promote tumor growth through an autocrine mechanism
- (2015) Stefania Raimondo et al. Cell Communication and Signaling
- Expression of the multidrug transporter P-glycoprotein is inversely related to that of apoptosis-associated endogenous TRAIL
- (2015) Paloma S. Souza et al. EXPERIMENTAL CELL RESEARCH
- Mechanisms and therapeutic potential of inhibiting drug efflux transporters
- (2015) Anna Klukovits et al. Expert Opinion on Drug Metabolism & Toxicology
- Molecular response to imatinib & its correlation with mRNA expression levels of imatinib influx & efflux transporters in patients with chronic myeloid leukaemia in chronic phase
- (2015) Hemant Malhotra et al. INDIAN JOURNAL OF MEDICAL RESEARCH
- Expression pattern of key microRNAs in patients with newly diagnosed chronic myeloid leukemia in chronic phase
- (2015) P. Fallah et al. International Journal of Laboratory Hematology
- Membrane microparticles: shedding new light into cancer cell communication
- (2015) Paloma Silva de Souza et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- In vitro and in vivo identification of ABCB1 as an efflux transporter of bosutinib
- (2015) Sara Redaelli et al. Journal of Hematology & Oncology
- Ponatinib is not transported by ABCB1, ABCG2 or OCT-1 in CML cells
- (2015) L Lu et al. LEUKEMIA
- Long-term outcome of chronic myeloid leukemia patients treated frontline with imatinib
- (2015) F Castagnetti et al. LEUKEMIA
- Safety and efficacy of imatinib in CML over a period of 10 years: data from the randomized CML-study IV
- (2015) L Kalmanti et al. LEUKEMIA
- MRP1 and P-glycoprotein expression assays would be useful in the additional detection of treatment non-responders in CML patients without ABL1 mutation
- (2015) Sang Hyuk Park et al. LEUKEMIA RESEARCH
- Drug transporters play a key role in the complex process of Imatinib resistance in vitro
- (2015) Raquel Alves et al. LEUKEMIA RESEARCH
- High serum levels of extracellular vesicles expressing malignancy-related markers are released in patients with various types of hematological neoplastic disorders
- (2015) Antonella Caivano et al. TUMOR BIOLOGY
- Association of genotypes and haplotypes of multi-drug transporter genes ABCB1 and ABCG2 with clinical response to imatinib mesylate in chronic myeloid leukemia patients
- (2014) Anthony Au et al. BIOMEDICINE & PHARMACOTHERAPY
- TIDEL-II: first-line use of imatinib in CML with early switch to nilotinib for failure to achieve time-dependent molecular targets
- (2014) D. T. Yeung et al. BLOOD
- MicroRNAs and their relevance to ABC transporters
- (2014) Sierk Haenisch et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Exosome-mediated crosstalk between chronic myelogenous leukemia cells and human bone marrow stromal cells triggers an Interleukin 8-dependent survival of leukemia cells
- (2014) Chiara Corrado et al. CANCER LETTERS
- MDR1 expression predicts outcome of Ph+ chronic phase CML patients on second-line nilotinib therapy after imatinib failure
- (2014) M Agrawal et al. LEUKEMIA
- Polymorphisms in the human organic cation transporter and the multidrug resistance gene: correlation with imatinib levels and clinical course in patients with chronic myeloid leukemia
- (2014) Jacob Vine et al. LEUKEMIA & LYMPHOMA
- Changes in gene expression profile in two multidrug resistant cell lines derived from a same drug sensitive cell line
- (2014) Miguel Angelo Martins Moreira et al. LEUKEMIA RESEARCH
- ABCB1 haplotypes but not individual SNPs predict for optimal response/failure in Egyptian patients with chronic-phase chronic myeloid leukemia receiving imatinib mesylate
- (2014) Mohamed A. M. Ali et al. MEDICAL ONCOLOGY
- Nilotinib Enhances the Efficacy of Conventional Chemotherapeutic Drugs in CD34+CD38− Stem Cells and ABC Transporter Overexpressing Leukemia Cells
- (2014) Fang Wang et al. MOLECULES
- Single nucleotide polymorphisms of multidrug resistance gene 1 (MDR1) and risk of chronic myeloid leukemia
- (2014) Kassogue Yaya et al. TUMOR BIOLOGY
- ABCB1 haplotypes are associated with P-gp activity and affect a major molecular response in chronic myeloid leukemia patients treated with a standard dose of imatinib
- (2014) DOUGLAS VIVONA et al. Oncology Letters
- In vitro Development of Chemotherapy and Targeted Therapy Drug-Resistant Cancer Cell Lines: A Practical Guide with Case Studies
- (2014) Martina McDermott et al. Frontiers in Oncology
- Friend or foe: the role of microRNA in chemotherapy resistance
- (2013) Haoran Li et al. ACTA PHARMACOLOGICA SINICA
- European LeukemiaNet recommendations for the management of chronic myeloid leukemia: 2013
- (2013) M. Baccarani et al. BLOOD
- Bosutinib safety and management of toxicity in leukemia patients with resistance or intolerance to imatinib and other tyrosine kinase inhibitors
- (2013) H. M. Kantarjian et al. BLOOD
- Assessment of treatment and monitoring patterns and subsequent outcomes among patients with chronic myeloid leukemia treated with imatinib in a community setting
- (2013) Mansoor N. Saleh et al. CURRENT MEDICAL RESEARCH AND OPINION
- Association of MDR1 gene polymorphism (G2677T) with imatinib response in Egyptian chronic myeloid leukemia patients
- (2013) Doaa M. Elghannam et al. Hematology
- The network of P-glycoprotein and microRNAs interactions
- (2013) Vanessa Lopes-Rodrigues et al. INTERNATIONAL JOURNAL OF CANCER
- XIAP and P-glycoprotein co-expression is related to imatinib resistance in chronic myeloid leukemia cells
- (2013) Karina Lani Silva et al. LEUKEMIA RESEARCH
- Phosphorylated Crkl reduction levels are associated with the lowest P-glycoprotein activity levels in cells from chronic myeloid leukemia patients
- (2013) Flavia Cunha Vasconcelos et al. LEUKEMIA RESEARCH
- Characterization of a multidrug-resistant chronic myeloid leukemia cell line presenting multiple resistance mechanisms
- (2013) Nathalia Daflon-Yunes et al. MOLECULAR AND CELLULAR BIOCHEMISTRY
- Apoptosis Sensitization by Euphorbia Factor L1 in ABCB1-Mediated Multidrug Resistant K562/ADR Cells
- (2013) Jian-Ye Zhang et al. MOLECULES
- A Phase 2 Trial of Ponatinib in Philadelphia Chromosome–Positive Leukemias
- (2013) J.E. Cortes et al. NEW ENGLAND JOURNAL OF MEDICINE
- Microparticles mediate MRP1 intercellular transfer and the re-templating of intrinsic resistance pathways
- (2013) Jamie F. Lu et al. PHARMACOLOGICAL RESEARCH
- Down-regulation of miR-181c in imatinib-resistant chronic myeloid leukemia
- (2013) Neda Mosakhani et al. Molecular Cytogenetics
- New Insight into P-Glycoprotein as a Drug Target
- (2012) Albert Breier et al. Anti-Cancer Agents in Medicinal Chemistry
- The pterocarpanquinone LQB 118 induces apoptosis in tumor cells through the intrinsic pathway and the endoplasmic reticulum stress pathway
- (2012) Thiago de Sá Bacelar et al. ANTI-CANCER DRUGS
- BCR-ABL1 compound mutations in tyrosine kinase inhibitor-resistant CML: frequency and clonal relationships
- (2012) J. S. Khorashad et al. BLOOD
- Regulation Exerted by miRNAs in the Promoter and UTR Sequences: MDR1/P-gp Expression as a Particular Case
- (2012) Julia D. Toscano-Garibay et al. DNA AND CELL BIOLOGY
- Association between imatinib transporters and metabolizing enzymes genotype and response in newly diagnosed chronic myeloid leukemia patients receiving imatinib therapy
- (2012) S. Angelini et al. HAEMATOLOGICA
- Imatinib increases apoptosis index through modulation of survivin subcellular localization in the blast phase of CML cells
- (2012) Paula Sabbo Bernardo et al. LEUKEMIA RESEARCH
- The Novel BCR-ABL and FLT3 Inhibitor Ponatinib Is a Potent Inhibitor of the MDR-Associated ATP-Binding Cassette Transporter ABCG2
- (2012) R. Sen et al. MOLECULAR CANCER THERAPEUTICS
- miR-181a Post-Transcriptionally Downregulates Oncogenic RalA and Contributes to Growth Inhibition and Apoptosis in Chronic Myelogenous Leukemia (CML)
- (2012) Jia Fei et al. PLoS One
- Role of P-glycoprotein in evolution of populations of chronic myeloid leukemia cells treated with imatinib
- (2011) T. P. Stromskaya et al. BIOCHEMISTRY-MOSCOW
- Dasatinib or imatinib in newly diagnosed chronic-phase chronic myeloid leukemia: 2-year follow-up from a randomized phase 3 trial (DASISION)
- (2011) H. M. Kantarjian et al. BLOOD
- ABCB1 haplotype is associated with major molecular response in chronic myeloid leukemia patients treated with standard-dose of imatinib
- (2011) Douglas Vivona et al. BLOOD CELLS MOLECULES AND DISEASES
- Interpretation of cytogenetic and molecular results in patients treated for CML
- (2011) Carlos E. Vigil et al. BLOOD REVIEWS
- Evolution of Therapies for Chronic Myelogenous Leukemia
- (2011) Fabio P. S. Santos et al. CANCER JOURNAL
- Molecular Pathways: BCR-ABL
- (2011) D. Cilloni et al. CLINICAL CANCER RESEARCH
- Microparticle-associated nucleic acids mediate trait dominance in cancer
- (2011) Ritu Jaiswal et al. FASEB JOURNAL
- Simultaneous targeting of P‐gp and XIAP with siRNAs increases sensitivity of P‐gp overexpressing CML cells to imatinib
- (2011) Hugo Seca et al. Hematology
- The predictive value of human organic cation transporter 1 and ABCB1 expression levels in different cell populations of patients with de novo chronic myelogenous leukemia
- (2011) Filip Razga et al. INTERNATIONAL JOURNAL OF HEMATOLOGY
- Overexpression of P-glycoprotein induces acquired resistance to imatinib in chronic myelogenous leukemia cells
- (2011) Xing-Xiang Peng et al. Chinese Journal of Cancer
- New pterocarpanquinones: Synthesis, antineoplasic activity on cultured human malignant cell lines and TNF-α modulation in human PBMC cells
- (2010) Chaquip D. Netto et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Polymorphisms in the multidrug resistance gene MDR1 (ABCB1) predict for molecular resistance in patients with newly diagnosed chronic myeloid leukemia receiving high-dose imatinib
- (2010) W. Deenik et al. BLOOD
- Long-term prognostic significance of early molecular response to imatinib in newly diagnosed chronic myeloid leukemia: an analysis from the International Randomized Study of Interferon and STI571 (IRIS)
- (2010) T. P. Hughes et al. BLOOD
- Variation of MDR proteins expression and activity levels according to clinical status and evolution of CML patients
- (2010) Flavia C. Vasconcelos et al. CYTOMETRY PART B-CLINICAL CYTOMETRY
- MiR-27a modulates MDR1/P-glycoprotein expression by targeting HIPK2 in human ovarian cancer cells
- (2010) Zhimin Li et al. GYNECOLOGIC ONCOLOGY
- Micro-RNA response to imatinib mesylate in patients with chronic myeloid leukemia
- (2010) S. Flamant et al. HAEMATOLOGICA
- Cytoplasmic expression of survivin is an independent predictor of poor prognosis in patients with salivary gland cancer
- (2010) Markus Stenner et al. HISTOPATHOLOGY
- LQB-118, a pterocarpanquinone structurally related to lapachol [2-hydroxy-3-(3-methyl-2-butenyl)-1,4-naphthoquinone]: a novel class of agent with high apoptotic effect in chronic myeloid leukemia cells
- (2010) Raquel C. Maia et al. INVESTIGATIONAL NEW DRUGS
- Down-regulated miR-331-5p and miR-27a are associated with chemotherapy resistance and relapse in leukaemia
- (2010) Dan-Dan Feng et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Human chronic myeloid leukemia stem cells are insensitive to imatinib despite inhibition of BCR-ABL activity
- (2010) Amie S. Corbin et al. JOURNAL OF CLINICAL INVESTIGATION
- Influence of CYP3A5 and drug transporter polymorphisms on imatinib trough concentration and clinical response among patients with chronic phase chronic myeloid leukemia
- (2010) Naoto Takahashi et al. JOURNAL OF HUMAN GENETICS
- Correlation between genetic polymorphisms of the hOCT1 and MDR1 genes and the response to imatinib in patients newly diagnosed with chronic-phase chronic myeloid leukemia
- (2010) Margherita Maffioli et al. LEUKEMIA RESEARCH
- MDR-1 polymorphisms (G2677T and C3435T) in B-chronic lymphocytic leukemia: an impact on susceptibility and prognosis
- (2010) G. Penna et al. MEDICAL ONCOLOGY
- Multidrug resistance gene (MDR1) polymorphisms correlate with imatinib response in chronic myeloid leukemia
- (2010) Ling-Na Ni et al. MEDICAL ONCOLOGY
- Dasatinib versus Imatinib in Newly Diagnosed Chronic-Phase Chronic Myeloid Leukemia
- (2010) Hagop Kantarjian et al. NEW ENGLAND JOURNAL OF MEDICINE
- The pharmacogenetics of imanitib
- (2010) Stéphanie Dulucq et al. Genome Medicine
- Molecular and cellular bases of chronic myeloid leukemia
- (2010) Yaoyu Chen et al. Protein & Cell
- Nilotinib (AMN107, Tasigna ® ) reverses multidrug resistance by inhibiting the activity of the ABCB1/Pgp and ABCG2/BCRP/MXR transporters
- (2009) Amit K. Tiwari et al. BIOCHEMICAL PHARMACOLOGY
- A synonymous polymorphism in a common MDR1 (ABCB1) haplotype shapes protein function
- (2009) King Leung Fung et al. BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS
- AP24534, a Pan-BCR-ABL Inhibitor for Chronic Myeloid Leukemia, Potently Inhibits the T315I Mutant and Overcomes Mutation-Based Resistance
- (2009) Thomas O'Hare et al. CANCER CELL
- Clinical Relevance of a Pharmacogenetic Approach Using Multiple Candidate Genes to Predict Response and Resistance to Imatinib Therapy in Chronic Myeloid Leukemia
- (2009) D. H. Kim et al. CLINICAL CANCER RESEARCH
- Nilotinib-mediated inhibition of ABCB1 increases intracellular concentration of dasatinib in CML cells: implications for combination TKI therapy
- (2009) D K Hiwase et al. LEUKEMIA
- Membrane microparticles mediate transfer of P-glycoprotein to drug sensitive cancer cells
- (2009) M Bebawy et al. LEUKEMIA
- Curcumin inhibits FtsZ assembly: an attractive mechanism for its antibacterial activity
- (2008) Dipti Rai et al. BIOCHEMICAL JOURNAL
- Role of MicroRNA miR-27a and miR-451 in the regulation of MDR1/P-glycoprotein expression in human cancer cells
- (2008) Hua Zhu et al. BIOCHEMICAL PHARMACOLOGY
- Multidrug resistance gene (MDR1) polymorphisms are associated with major molecular responses to standard-dose imatinib in chronic myeloid leukemia
- (2008) S. Dulucq et al. BLOOD
- DNA damage and endoplasmic reticulum stress mediated curcumin-induced cell cycle arrest and apoptosis in human lung carcinoma A-549 cells through the activation caspases cascade- and mitochondrial-dependent pathway
- (2008) Song-Shei Lin et al. CANCER LETTERS
- Evidence that Resistance to Nilotinib May Be Due to BCR-ABL, Pgp, or Src Kinase Overexpression
- (2008) F.-X. Mahon et al. CANCER RESEARCH
- An overview of cancer multidrug resistance: a still unsolved problem
- (2008) H. Lage CELLULAR AND MOLECULAR LIFE SCIENCES
- Dasatinib Cellular Uptake and Efflux in Chronic Myeloid Leukemia Cells: Therapeutic Implications
- (2008) D. K. Hiwase et al. CLINICAL CANCER RESEARCH
- P-glycoprotein: So Many Ways to Turn It On
- (2007) Richard Callaghan et al. JOURNAL OF CLINICAL PHARMACOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now